Art Van Charity Challenge: Bonus Challenge #5

Like the rock band Europe sang, "It's the final countdown."
Photo source.
The final countdown has begun. We are now in the last week of the Art Van Charity Challenge and there’s one bonus challenge left.

Since the Challenge began four weeks ago we’ve raised over $9,100 but we still have work to do to make it into the top ten and win the Art Van grant. Of course all the money we raise will directly help fund Angela Hospice’s compassionate grief support services for children and adults.

The final bonus challenge will run until 1:59 p.m. on June 22, which is also when the Challenge ends. Every charity that raises at least $100 this week will be entered for a chance to win $1,000. Every charity that raises at least $400 will be entered for a chance to win $4,000. So your donation can translate into a big prize for Angela Hospice!

This is the last week to donate to our CrowdRise page, so please click here, and also share this link with your friends and family: https://www.crowdrise.com/ahhc-artvan2015

And a reminder: all donations must be made through our CrowdRise page in order to count towards the Challenge.

Thank you to everyone that has supported Angela Hospice during this Challenge, whether by donating, becoming fundraisers, or sharing our CrowdRise page. We simply couldn’t fund programs like our grief counseling and support groups without your generous help.

If you can make a donation again today to help us during this final week, we would be so grateful! We’ll keep you all updated after the Challenge is officially over and tell you how we did.

For now, we’ll leave you with this: https://www.youtube.com/watch?v=9jK-NcRmVcw

If you have any questions please contact our campaign coordinators:
Dana Casadei: (734) 953-6053 or Dcasadei@angelahospice.us
Lisa Norton: (734) 953-6008 or Lnorton@angelahospice.us

Comments

Popular posts from this blog

A Room for Brian

Volunteer Spotlight: Ingrid Lasley

Detroit Catholic Central Moms Celebrate Hospice Workers During COVID-19